Company Overview and News

 
Apollo Hospitals Enterprise Limited - Updates

2018-10-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Updates

2018-10-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo Hospitals gets shareholders’ nod to raise ₹ 500 cr via NCDs

2018-09-28 thehindubusinessline
Healthcare major Apollo Hospitals Enterprise on Friday said it has received shareholders’ nod to raise up to ₹ 500 crore through issuance of non-convertible debentures (NCD) on a private placement basis.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Change in Director(s)

2018-09-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
India's Modi launches health insurance for 100 million families ahead of elections

2018-09-23 channelnewsasia
Indian Prime Minister Narendra Modi launched the world's biggest healthcare programme on Sunday, aiming to provide free health services to half a billion poor people, which could boost his chances in national elections early next year.
508869 APOLLOHOSP

 
Q1 results: Apollo Hospitals is back on investors’ radar

2018-08-17 livemint
The Apollo Hospitals Enterprise Ltd shares have gained 20% from its June quarter (Q1) results announcement last week. Profitability improved during the quarter, while losses at new hospitals tapered, stoking optimism that the company is on the threshold of a revival in earnings.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Financial Result Updates

2018-08-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Trading Window

2018-07-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo buys 50% stake in Lucknow healthcare project

2018-07-09 freepressjournal.in
New Delhi : Apollo Hospitals on Thursday said it has acquired a 50 per cent stake in a Lucknow-based 330-bed super speciality hospital project for a consideration of Rs 91 crore.
508869 APOLLOHOSP

 
Apollo Hospitals acquire 50% stake in Lucknow-based healthcare project

2018-07-05 moneycontrol
Apollo Hospitals today said it has acquired 50 percent stake in a Lucknow-based 330-bed super speciality hospital project for a consideration of Rs 91 crore. The acquisition of 50 percent stake in Medics Super Speciality Hospital would help the Chennai-based healthcare major to consolidate its position in Uttar Pradesh, Apollo Hospitals Enterprise said in a regulatory filing.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Press Release

2018-07-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Updates

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Apollo Hospitals Enterprise Limited - Updates

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
508869 APOLLOHOSP

 
Delhi's proposal to cap drug costs worries Indian hospitals industry

2018-06-01 channelnewsasia
NEW DELHI: Indian authorities have proposed capping medical costs at private hospitals in the capital to help millions of people, but the plan would deal a blow to the multi-billion-dollar healthcare sector already grappling with price control policies.
508869 FORTIS APOLLOHOSP 532843

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...